Wellington Management Group LLP raised its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 517.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 175,152 shares of the medical device company's stock after acquiring an additional 146,771 shares during the quarter. Wellington Management Group LLP owned approximately 0.09% of Cooper Companies worth $16,102,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of COO. Fulton Bank N.A. lifted its position in Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after buying an additional 109 shares during the period. Torray Investment Partners LLC lifted its stake in shares of Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after buying an additional 132 shares in the last quarter. Mather Group LLC. lifted its position in shares of Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after acquiring an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its stake in Cooper Companies by 15.6% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after purchasing an additional 136 shares during the period. Finally, Greenleaf Trust grew its holdings in Cooper Companies by 5.0% during the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company's stock valued at $268,000 after buying an additional 139 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research firms have issued reports on COO. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus lowered their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Robert W. Baird reduced their target price on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Finally, Piper Sandler reissued an "overweight" rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $110.25.
Check Out Our Latest Stock Report on COO
Cooper Companies Stock Down 0.2 %
Shares of COO stock traded down $0.13 on Monday, hitting $77.33. The stock had a trading volume of 178,015 shares, compared to its average volume of 1,391,377. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The business has a 50 day moving average price of $84.64 and a 200 day moving average price of $94.52. The company has a market cap of $15.46 billion, a PE ratio of 39.66, a P/E/G ratio of 2.25 and a beta of 1.01.
Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.
Cooper Companies Profile
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
